Arvinas Board Member Boosts Stake with Major Equity Grant - Bullish Signal?

Rhea-AI Filing Summary

Director John D. Young of Arvinas reported significant equity compensation grants on June 25, 2025, consisting of two main components:

• 16,025 Restricted Stock Units (RSUs) granted at $0, increasing his direct common stock ownership to 26,045 shares
• 23,105 Stock Options with an exercise price of $7.80 per share, expiring June 24, 2035

Both the RSUs and stock options are subject to vesting conditions, with full vesting occurring on the earlier of June 25, 2026 or the first board meeting following the next annual stockholder meeting. The grants are contingent on Young's continued service with Arvinas. The Form 4 was filed through his attorney-in-fact, Jared Freedberg, on June 27, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

YOUNG JOHN D

(Last) (First) (Middle)

C/O ARVINAS, INC.

5 SCIENCE PARK, 395 WINCHESTER AVE.

(Street)

NEW HAVEN CT 06511

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARVINAS, INC. [ ARVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/25/2025		A		16,025(1)	A	$0	26,045	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$7.8	06/25/2025		A		23,105		(2)	06/24/2035	Common Stock	23,105	$0	23,105	D

Explanation of Responses:

1. The restricted stock units (each, an "RSU") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.

2. This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.

Remarks:

	/s/ Jared Freedberg, as attorney-in-fact for John Young	06/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many ARVN stock options did John Young receive on June 25, 2025?

John Young received 23,105 stock options with an exercise price of $7.80 per share on June 25, 2025. These options will expire on June 24, 2035.

What is the vesting schedule for ARVN's RSUs granted to John Young?

The 16,025 RSUs granted to John Young on June 25, 2025 will vest in full on the earlier of: (1) June 25, 2026 or (2) the first board meeting held after the next annual stockholders meeting, subject to his continued service with Arvinas.

How many shares of ARVN common stock does John Young own directly after the June 25, 2025 transactions?

Following the reported transactions, John Young directly owns 26,045 shares of Arvinas common stock. This amount reflects his holdings after receiving 16,025 RSUs on June 25, 2025.

What is John Young's role at ARVN according to the Form 4?

According to the Form 4 filing, John Young serves as a Director of Arvinas, Inc. (ARVN). This is indicated by the 'X' marked in the Director box under the Relationship of Reporting Person(s) to Issuer section.

When do John Young's new ARVN stock options expire?

The stock options granted to John Young on June 25, 2025 have an expiration date of June 24, 2035, giving them a 10-year term from the grant date.